Antibody development for preventing the human respiratory syncytial virus pathology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antibody development for preventing the human respiratory syncytial virus pathology ; volume:26 ; number:1 ; day:17 ; month:4 ; year:2020 ; pages:1-10 ; date:12.2020
Molecular medicine ; 26, Heft 1 (17.4.2020), 1-10, 12.2020
- Urheber
-
Soto, Jorge A.
Gálvez, Nicolás M. S.
Pacheco, Gaspar A.
Bueno, Susan M.
Kalergis, Alexis M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-020-00162-6
- URN
-
urn:nbn:de:101:1-2020062920581404335654
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Soto, Jorge A.
- Gálvez, Nicolás M. S.
- Pacheco, Gaspar A.
- Bueno, Susan M.
- Kalergis, Alexis M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Severe Respiratory Syncytial Virus Infection
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
Das Respiratory syncytial Virus : Eine Durchseuchungsstudie
Das Respiratory-Syncytial-<RS>-Virus-Antigen
An update on respiratory syncytial virus
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure
Human Respiratory Syncytial Virus Detected in Mountain Gorilla Respiratory Outbreaks
Immunoprophylaxis of respiratory syncytial virus: global experience
Interventions against the Respiratory Syncytial Virus Infection
Severe Respiratory Syncytial Virus Infection
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
Das Respiratory syncytial Virus : Eine Durchseuchungsstudie
Das Respiratory-Syncytial-<RS>-Virus-Antigen
An update on respiratory syncytial virus
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure
Human Respiratory Syncytial Virus Detected in Mountain Gorilla Respiratory Outbreaks
Immunoprophylaxis of respiratory syncytial virus: global experience
Interventions against the Respiratory Syncytial Virus Infection
Severe Respiratory Syncytial Virus Infection
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections
Das Respiratory syncytial Virus : Eine Durchseuchungsstudie
Das Respiratory-Syncytial-<RS>-Virus-Antigen
An update on respiratory syncytial virus
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
Heliox reduces respiratory system resistance in respiratory syncytial virus induced respiratory failure
Human Respiratory Syncytial Virus Detected in Mountain Gorilla Respiratory Outbreaks
Immunoprophylaxis of respiratory syncytial virus: global experience